Average Co-Inventor Count = 5.0

ph-index = 5

Forward Citations = 75(Granted Patents)

Location History:

Bielefeld, DE (1987 - 1993)
Frankfurt-am-Main, DE (1995 - 2005)

Company Filing History:

8 out of 112

Asta Medica, Aktiengesellschaft

Asta Pharma Aktiengesellschaft

patents

4. 1 out of 1

Asta Medica Aktiengellschaft

patent

5. 1 out of 6

Asta-werke Aktiengesellschaft, Chemische Fabrik

Years Active: 1987-2005

Loading Chart...

17 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 6903080 - Disease treatment with novel phospholipid derivatives (2005-06-07),

2. 6696428 - Use of dopamine receptor antagonists in palliative tumor therapy (2004-02-24),

3. 6576624 - Use of dopamine receptor antagonists in palliative tumor therapy (2003-06-10),

4. 6544551 - Solid pharmaceutical compositions containing hexedecylphosphocholine (miltefosine) for oral administration in the treatment of leishmaniasis (2003-04-08),

5. 6479472 - Methods of using therapeutic phospholipid derivatives (2002-11-12),

6. 6172050 - Phospholipid derivatives (2001-01-09),

7. 6093704 - Use of dopamine receptor antagonists in palliative tumor therapy (2000-07-25),

8. 5958906 - Phospholipid derivatives containing higher elements of the fifth main (1999-09-28),

9. 5773032 - Long-acting injection suspensions and a process for their preparation (1998-06-30),

10. 5663145 - Products for administering an initial high dose of Cetrorelix and (1997-09-02),

11. 5637577 - Phospholipid derivatives containing higher elements of the fifth group (1997-06-10),

12. 5449798 - Phospholipid derivatives containing higher elements of the fifth group (1995-09-12),

13. 5238955 - Ethylene-substituted phenylalkylethylenediamine-platinum (II or IV) (1993-08-24),

14. 5219866 - Octadecyl-[2-(N-methylpiperidino)-ethyl]-phosphate and a process for its (1993-06-15),

15. 5194644 - Ethylene-substituted phenylalkylethylene-diamine-platinum (II or IV) (1993-03-16),

Title: The Innovative Mind of Peter Hilgard

Introduction

Peter Hilgard, an inventive force based in Frankfurt-am-Main, Germany, has made significant contributions to the field of medical chemistry. With an impressive portfolio of 17 patents, Hilgard's work focuses primarily on the treatment of various diseases using innovative chemical compounds. His research has paved the way for advancements in therapeutic methods for conditions often resistant to traditional treatments.

Latest Patents

Hilgard's latest patents reflect his dedication to addressing pressing health challenges. One notable patent details a method for treating protozoal and fungal diseases through the administration of novel phospholipid derivatives. This innovative approach aims to effectively manage infections that can severely impact patients' health. Furthermore, he has developed methods to treat bone marrow damage caused by cytostatic agents, helping restore functionality in patients enduring intensive cancer treatments.

Another significant contribution from Hilgard involves the use of dopamine receptor antagonists in palliative tumor therapy. His research demonstrates that the side effects, particularly weight loss, induced by alkylphosphocholines such as miltefosine, can be countered by certain acetylcholine receptor antagonists. This combination has shown potential without compromising the anti-tumor efficacy, highlighting his focus on improving patient quality of life during treatment.

Career Highlights

Throughout his career, Hilgard has collaborated with esteemed companies in the pharmaceutical sector. Notably, he has worked with Asta Medica and Zentaris AG, contributing to the development of innovative therapies designed to tackle challenging medical conditions. His experience in these organizations has been instrumental in translating his research into practical applications that benefit patients.

Collaborations

Peter Hilgard's remarkable work is also supported by collaborations with notable individuals in the industry, including Jurgen Engel and Bernhard Kutscher. These partnerships have allowed for the pooling of expertise and resources, fostering an environment where innovative ideas can flourish and lead to tangible advancements in medicine.

Conclusion

Peter Hilgard stands out as a prominent inventor whose patents and research have significantly impacted the medical field. His dedication to developing innovative treatment methods showcases the importance of research and collaboration in advancing healthcare solutions. As he continues to push the boundaries of medical chemistry, the potential for his contributions to improve patient outcomes remains vast and inspiring.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.